| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 433 | 54.837 | 94.345 | 106.776 | 140.830 | 168.066 | 241.554 | 259.071 | 285.196 |
| Total Income - EUR | 0 | 433 | 56.808 | 94.732 | 110.570 | 142.695 | 168.069 | 243.319 | 266.806 | 289.502 |
| Total Expenses - EUR | 0 | 433 | 42.216 | 45.703 | 57.912 | 83.449 | 103.621 | 123.761 | 123.565 | 190.449 |
| Gross Profit/Loss - EUR | 0 | 0 | 14.592 | 49.030 | 52.658 | 59.246 | 64.447 | 119.559 | 143.242 | 99.054 |
| Net Profit/Loss - EUR | 0 | 0 | 14.043 | 48.084 | 51.590 | 57.838 | 62.968 | 117.143 | 140.651 | 90.409 |
| Employees | 0 | 1 | 2 | 2 | 2 | 4 | 4 | 4 | 4 | 5 |
Check the financial reports for the company - Nord Medline Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 852 | 585 | 1.656 | 2.877 | 3.840 | 58.548 | 59.997 | 54.518 | 50.238 | 45.346 |
| Current Assets | 200 | 677 | 15.457 | 51.998 | 80.172 | 83.445 | 135.271 | 306.262 | 139.511 | 239.726 |
| Inventories | 112 | 157 | 345 | 582 | 850 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 88 | 520 | 6.131 | 7.132 | 14.813 | 26.118 | 13.329 | 89.903 | 25.719 | 13.263 |
| Cash | 0 | 1 | 8.981 | 44.285 | 64.509 | 57.327 | 121.942 | 216.359 | 73.359 | 226.463 |
| Shareholders Funds | 309 | 306 | 14.344 | 48.379 | 51.879 | 108.734 | 169.291 | 117.192 | 181.398 | 262.952 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.287 | 8.417 | 2.769 | 6.497 | 32.133 | 33.259 | 25.978 | 243.587 | 8.351 | 22.121 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nord Medline Srl